Minor
Intratumoral PH-762 for Cutaneous Carcinoma
Trial completed
Also in this update: Final enrollment: 22 participants (planned 30)
Phio Pharmaceuticals Inc.Phase 1 NCT06014086 Registry history of NCT06014086 on ClinicalTrials.gov (opens the registry)